Jennie Wagy Winstead currently serves as Senior Manager in CMC Analytical Development at SpringWorks Therapeutics, a role held since December 2021, focusing on drug development for severe rare diseases and cancer. Previous experience includes leadership positions in method development and validation at Mayne Pharma, as well as managerial roles in analytical sciences at Recipharm. Jennie has also held positions at Tergus Pharma, Merck, and Hospira, with a solid foundation in analytical chemistry starting as a Laboratory Analyst. Academic qualifications include a Bachelor's degree in Chemistry and Biology from Barton College, completed in 2012.
This person is not in any offices